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A B S T R A C T
Both patients with schizophrenia and with a major depressive disorder (MDD) display deficits in identifying
facial expressions of emotion during acute phases of their illness. However, specific deficit patterns have not yet
been reliably demonstrated. Tasks that employ emotionally ambiguous stimuli have recently shown distinct
deficit patterns in patients with schizophrenia compared to other mental disorders as well as healthy controls.
We here investigate whether a task which uses an ambiguous Japanese (Noh) mask and a corresponding human
stimulus generates distinctive emotion attribution patterns in thirty-two Caucasian patients with schizophrenia,
matched MDD patients and healthy controls. Results show that patients with schizophrenia displayed reaction
time disadvantages compared to healthy controls while identifying sadness and anger. MDD patients were more
likely to label stimuli with basic compared to subtle emotional expressions. Moreover, they showed more dif-
ficulties assigning emotions to the human stimulus than to the Noh mask. IQ, age and cognitive functioning did
not modulate these results. Because overall group differences were not observed, this task is not suitable for
diagnosing patients. However, the subtle differences that did emerge might give therapists handles that can be
used in therapy.
1. Introduction
Specific impairments in patients with schizophrenia have been
identified in tasks that employ the identification of emotions diverging
from prototypical, basic expressions of emotion (Burch, 1995), such as
subtle (Tremeau et al., 2015) and ambiguous emotions (Ketteler et al.,
2012; Tsui et al., 2013). Tasks that use facial stimuli with (morphed)
faces showing different degrees of emotional intensity have been pro-
posed to aid the identification of differential deficits because of their
ambiguous nature, leaving some room for a different interpretation
(Huang et al., 2011; Moritz et al., 2012). However, apart from a few
exceptional studies, conventional emotion identification tasks employ
full-strength emotional expressions which might be identified more
easily than ambiguous (Tsui et al., 2013) or more subtle emotion ex-
pressions (Tremeau et al., 2015) and thus yield ceiling effects.
Emotion recognition deficits may relate to the specific symptoma-
tology of patients with schizophrenia and, including ideas of reference
(Frith, 2004) may presumably lead to an interference of symptoms with
emotion identification, e.g., the disturbance of cognitive processing of
emotions due to hallucinations or thought disorders (Park et al., 2011).
Moreover, disorganized symptoms have been found to correlate with
lower abilities to identify negative emotions (Comparelli et al., 2014).
These findings are in line with the findings of studies demonstrating
that patients with schizophrenia have deficits identifying negative
emotions (Bell et al., 1997) and thus tend to perceive ambiguous
emotions as more positive (Tsui et al., 2013). However, studies on facial
emotion recognition in schizophrenia observed an interpretation bias
toward negative emotions in patients with paranoid symptoms
(Pinkham et al., 2011). Further, other work showed that patients with
schizophrenia and concurrent depression recognized sadness more
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accurately compared to those patients with no additional depressive
symptoms (Herniman et al., 2017). This is in line with findings that
have reported a bias toward negative emotions in patients with an MDD
(Hale, 1998). Ventura et al. (2013b) found negative associations be-
tween emotion recognition abilities and reality distortion, negative
symptoms and disorganization. Finally, another study on patients with
schizophrenia, divided by their either positive or negative symptoms in
comparison to healthy controls, observed a recognition bias toward
positive emotional expressions in patients with predominantly positive
symptoms and a generalized emotion recognition deficit in negative
symptom schizophrenia (Mandal et al., 1999). Thus, the literature is not
conclusive regarding the putative emotion processing deficits on ex-
plicit, prototypical facial expressions. As expressions in daily life are
hardly ever as clear and unambiguous as the prototypes used in the
laboratory (Kret, 2015), we here propose to use an alternative paradigm
to shed some new light onto this discussion.
Minoshita and colleagues (1999) introduced a novel paradigm, the
Noh mask test, which demands the identification of ambiguous emo-
tions. The stimuli consist of photos of a female wooden mask, taken
from the Japanese Noh theatre (for examples of the stimuli see
Supplement 1). Making use of differences in lighting and flipping angle
(Kawai et al., 2013), the mask displays changing emotional expressions,
thus creating ambiguity (Miyata et al., 2012). On this task, Japanese
patients with schizophrenia showed an emotion identification pattern
different from that of healthy controls, including a reduced sensitivity
to negative emotions (Minoshita et al., 2005). As the Noh mask re-
presents a single non-human object, the stimulus material is homo-
geneous and biases due to subjective feelings toward the face models
are reduced (Yrizarry et al., 1998). Moreover, in the context of an un-
familiar cultural group (out-group), emotion identification is generally
more difficult (Adams et al., 2010) while subcategories of emotions are
identified more easily in members of the own cultural group
(Russell, 1991). The Noh mask with its out-group features creates a
homogeneous, ambiguous emotional stimulus, which might therefore
serve as a beneficial instrument for the diagnosis of schizophrenia, e.g.
in the early stages of the illness. Moreover, its more dynamic approach
with different view angles might be beneficial, as it has been shown that
manipulations of viewing perspectives, e.g. presenting in peripheral
visions (Goren and Wilson, 2006), compromises the identification of
emotions. Studies directly comparing patients with schizophrenia and
affective disorders are rare. One study, however, is particularly in-
formative in this respect. In this study, in which the Noh mask test was
given to healthy German volunteers (Koelkebeck et al., 2015), a bias
towards positive emotions over all participants was shown. However,
there were also reaction time disadvantages present on the Noh mask
test as compared to standard emotion identification tasks in healthy
participants with relatively high alexithymic and anxious traits. Whe-
ther these findings would be amplified in clinical patients is still an
open question. In this respect, general reaction time slowing
(Braff, 1993) and deficits in emotion perception in patients with schi-
zophrenia in comparison to healthy controls have also been shown
(Baudouin et al., 2002; Belge et al., 2017). A pattern of reaction time
slowing has also been found in patients with schizophrenia with an
additional affective flattening (Suslow et al., 2003), but see
Derntl et al. (2012).
In the current study, the Noh mask test will be used to investigate
potential deficits in the perception of ambiguous expressions of emotion
in schizophrenia and major depressive disorder (MDD) patients in
comparison to healthy controls. We expect that this task will allow us to
tap into these deficits better than conventional tasks and help to solve
the ambiguity in the literature. With our study, we aim to validate
several hypotheses. We predict that patients with schizophrenia have
an overall reaction time slowing as compared to both patients with an
MDD and healthy controls. We moreover hypothesize that this effect
would be more prominent in the Noh mask stimuli than in a condition
involving human Asian faces. We furthermore predict that patients with
schizophrenia would show a bias toward positive emotional expres-
sions. In patients with an MDD, we hypothesize a bias toward negative
emotions. In healthy controls, we expect an overall general positive bias
regarding the Noh masks. In addition, we investigate individual dif-
ferences in cognitive functioning (Ventura et al., 2013a), IQ
(Andric et al., 2016) and age (West et al., 2012) and their putative
modulatory effects on task performance.
2. Materials and methods
2.1. Participants
All patients were recruited from the Department of Psychiatry and
Psychotherapy of the University of Muenster. In total, 115 participants
were assessed. Due to high scores in the Beck Depression Inventory
(BDI-r; Beck et al., 1961) (patients with schizophrenia> 19 points (cut-
off: medium severity), healthy controls> 9 points (cut-off: mild se-
verity)), concurrent Structured Clinical Interview (SCID; APA, 1994)
diagnoses, severe neuropsychological abnormalities or an Asian back-
ground, eleven patients with schizophrenia, two patients with an MDD
and six healthy controls had to be excluded. The final sample consisted
of 32 in- and out-patients diagnosed with schizophrenia or psychotic
spectrum disorder, 32 patients with an MDD and 32 physically and
mentally healthy German residents matched on age, gender and edu-
cation. All participants completed the BDI and the Montgomery-Asberg
Depression Rating Scale (MADRS; Montgomery and Asberg, 1979).
Both patient groups were assessed with the Clinical Global Impression
(CGI; Guy, 1976) and the Global Assessment of Functioning (GAF;
APA, 1987) instruments and patients with schizophrenia were ad-
ditionally assessed on the Positive and Negative Syndrome Scale
(PANSS; Kay et al., 1987). Diagnoses were made according to the DSM
IV criteria as assessed by a trained and experienced interviewer with
the SCID I interview. All data presented in the following refer to the
final sample of participants.
Diagnoses included paranoid (n=19), disorganized (n=2), re-
sidual (n=3) and undifferentiated schizophrenia (n=2) as well as
schizoaffective disorder (n=6). All patients with schizophrenia or
psychotic spectrum disorder were treated with antipsychotic medica-
tion. Two patients received lorazepam and one patient diazepam.
Benzodiazepine treatment, however, was restricted to a maximum of
5mg diazepam or 1mg lorazepam prior to 48 hours before the testing.
For details on medication, see Supplement 2.
Patients with depression were not included if they had a previous
treatment with electroconvulsive therapy. Diagnoses included a single
depressive episode of medium severity (n=1) as well as recurrent
depressive episodes with medium (n=18) and severe characteristics
(n=13). All patients were treated with antidepressant medication. One
patient was treated with 1mg lorazepam. For details on medication, see
Supplement 2.
All patients were clinically stabilized during the time of the testing
and within the age of 18–55 years. Participants with any history of
other psychiatric disorders, neurological or severe internal medical
disorders, serious head injuries, acute alcohol or illegal drug abuse or
dependence were not included in the study. Healthy controls were not
included if they reported a present or a previous mental disorder or a
first-grade relative with a mental disorder. None of the participants had
ever seen the Noh mask stimulus before or were engaged in Japanese or
other Asian culture. The visual acuity of all participants was sufficient
for participation in the study and all had good command of the German
language.
Written informed consent was obtained from all participants. The
design of this study was approved by the Ethics Committee of the
University of Muenster and the Westphalian State Chamber of
Physicians (2013-104-f-S). The authors assert that all procedures con-
tributing to this work comply with the ethical standards of the relevant
national and institutional committees on human experimentation and
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with the Helsinki Declaration of 1975, as revised in 2008 (https://
www.wma.net/policies-post/wma-declaration-of-helsinki-ethical-
principles-for-medical-research-involving-human-subjects/; last access
to all websites October 27, 2018).
2.2. Procedure and apparatus
All computer-assisted tasks were presented on a notebook using the
program Inquisit 4 (http://www.millisecond.com/). First, color pho-
tographs of a painted wooden female mask were presented to partici-
pants (Minoshita et al., 2005; see Supplement 1 for examples). The
photos showed the mask in nine different inclination angles, eight tilted
in angular degrees of 10 (10°−40°) up (u)- and downwards (d) on the
vertical line as well as one photo showing a full-frontal view of the
mask. In addition, we used a set of nine photos of a tilted neutral Ja-
panese female face (10°, 20°, 25°, 30° up- and downward, one frontal
view; please refer to Lyons et al. (2000); see Supplement 1 for ex-
amples). For each photo, participants were asked to consider one out of
ten emotion expressions (e.g., “does this person look sad?”). Five basic
emotions (sad, angry, fearful, disgusted, happy) and five subcategories
or subtle emotions (gloomy, relaxed, shy, startled, apathetic) were
presented in written form for 500ms. Participants were to answer
spontaneously “yes” or “no” with a digital key press and were, after six
seconds, reminded to answer. Ten blocks (i.e., different emotion ex-
pressions) were presented with nine trials (i.e., different inclination
angles of the Noh mask and Japanese female face) each, with a short
break after 90 trials. All stimuli were presented in random order. In
total, 180 trials were presented. Prior to the session, two additional
blocks served as practice trials to introduce the task to patients, using
Noh masks and Japanese female faces not included in the main task,
which presented two additional emotions (hope, ecstasy). After each
trial, a pixelated distractor in gray scale was shown. For both tasks,
reaction times (in ms) as well as the rates of confirmation of the emo-
tion expression was recorded. The performance duration on the com-
puter-assisted task was about 10–15 min, depending on the condition of
the participant.
2.3. Questionnaires, psychopathology ratings and cognitive tests
Participants completed the Empathy Quotient (EQ; Baron-
Cohen and Wheelwright, 2004), which is a 60-item questionnaire that
measures empathic abilities with a four-point response format (from “I
strongly agree” to “I strongly disagree”). Moreover, the Toronto Alex-
ithymia Scale (TAS-26; Taylor et al., 2003), a self-report instrument
that detects difficulties in identifying (subscale 1) and describing
(subscale 2) emotions and a tendency to externally focus attention
(subscale 3) was used. It presents 26 items which have to be answered
on a five-point scale (from “1= certainly does not apply to me” to
“5= certainly does apply to me”). To characterize participants by their
cognitive functioning, we assessed crystallized intelligence by means of
the Multiple Choice Vocabulary Intelligence Test (MWT-B; Lehrl, 2005).
The Trail-Making Test (TMT A and B; Reitan, 1958) was used as a
cognitive flexibility measure assessing visual attentional abilities and
processing speed as well as executive functioning. Lastly, clinical (e.g.,
medication) and social (e.g., education) data were assessed.
2.4. Statistical analyses
All data were processed with IBM SPSS Statistics 25.0. There were
two dependent variables: (1) Reaction times; (2) Emotion Confirmation.
For the analysis of these dependent variables we used a multilevel
mixed model for nested data with trials (180) nested in subjects (96)
(see also Kret and de Gelder, 2013; Kret and de Dreu, 2013). Fixed
factors included Experimental Condition (2: Noh Mask; Japanese Fe-
male Face), Emotion Category (2: Basic Emotion; Subtle Emotion),
Group (3: Schizophrenia; MDD; Control Group) and their interactions.
This multi-level method allows for the inclusion of all data without first
having to average unique datapoints over trials (and losing important
variance in the data). Thus, each single datapoint (reaction time or
emotion confirmation on a single trial) was fed into the analysis.
Moreover, this method has the advantage of including a random in-
tercept per subject, accounting for individual variability in the re-
sponses. Starting from a full model, non-significant factors were ex-
cluded one by one, beginning with three-way interactions until the
most parsimonious, best-fitting model was reached. This bottom-up and
data-driven approach is especially preferred because of the large in-
consistencies in findings that have been described in the literature. For
example, instead of conducting a repeated measures ANOVA where the
researcher predetermines the design of the statistical model, our model-
selection procedure allows the data more room to speak for itself and
enables the researcher to select the model that best fits the data. Still,
the model will never be able to explain all of the variance that is present
in the data and, as a consequence, will never be perfect. For that reason
and since for the computation of an effect size one assumption is that
the statistical model is (impossibly) a perfect fit, effect sizes cannot be
computed with this procedure.
Prior to analysis, reaction times were filtered to exclude extreme
responses exceeding 8.000ms, which led to the exclusion of 0.08% of
all trials. For the analysis of reaction times, a gamma distribution was
used to allow for the skewness of the data (skewed, non-normal data is
typical for reaction times). In a first generalized mixed model, we aimed
to predict reaction times by including the fixed factors Group
(Schizophrenia; MDD; Control Group), Condition (Noh Mask; Japanese
Female Face), Emotion Type (Basic Emotion; Subtle Emotion) and their
interactions. We used this latter emotion categorization in consistence
with previous studies using the Noh mask, where a difference was made
between subtle and basic emotion (Minoshita et al., 1999, 2005).
However, in a follow-up analysis we also analyze the effects of the ten
unique expressions (sad, angry, fearful, disgusted, happy, gloomy, re-
laxed, shy, startled, apathetic). The follow-up simple contrasts were
adjusted for multiple comparisons using Fisher's Least Significant Dif-
ference Test, also known as LSD.
For the analysis of confirmation rates, a binary distribution func-
tion (0= no; 1= yes) was chosen. For the rest, the statistical procedure
was identical to the procedure regarding the reaction times. As the first
model of the confirmation rates did not show any interaction effect of
Emotion Type (Basic Emotion and Subtle Emotion) and Group, we did
not follow this model up with a model that included all ten emotions.
For the analysis of questionnaire and social data, χ2-tests orMann-
Whitney-U tests were used where appropriate.
As the main focus of the study was the investigation of differences
between patients with schizophrenia, MDD and healthy controls, we
only report significant effects involving factors that include “Group” in
the analyses below. All other effects are reported in the tables (see
Tables 3–5).
3. Results
3.1. Questionnaires and assessment of clinical variables
Overall, participants did not reach the cut-off scores for pathological
values on the TAS and EQ. Patients with an MDD had the lowest values
on the EQ and the highest values on the subscales identifying and de-
scribing emotions as well as the sum score of the TAS. The healthy
controls scored highest on the externally oriented thinking subscale of
the TAS. IQ was significantly different between groups and lowest in
the schizophrenia sample. Reduced intellectual abilities in patients with
schizophrenia have been described repeatedly and this intellectual de-
cline is a problem immanent to the disorder (Keefe et al., 2005;
Koelkebeck et al., 2005). On the TMT, the patients with schizophrenia
were slowest. As expected, BDI and MADRS values were highest in MDD
patients and intermediate in patients with schizophrenia (see Table 1
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for all results). In Table 2 we present the mean reaction time results and
confirmation rates of all groups as well as the standard deviations.
3.2. Generalized mixed model analyses
3.2.1. Reaction times
The results showed an interaction effect between Group
(Schizophrenia, MDD or Healthy Controls) * Experimental Condition
(Noh Mask or Japanese Female Face, F(17.077)= 5.112, p=0.006),
showing that patients with an MDD, compared to those with schizo-
phrenia or healthy controls, displayed a somewhat blunted pattern of
the typically much faster responses following the categorization of
emotions from naturalistic faces relative to ambiguous stimuli (contrast
Noh Mask versus Japanese Female Face for MDD t(17.077)= 2.226,
p=0.026; schizophrenia t(17.077)= 5.201, p<0.001; healthy con-
trols t(17.077)= 6.252, p<0.001) (see Table 3). Further, a significant
interaction was observed between Emotion Type (Basic or Subtle) *
Group (F(17.077)= 3.614, p=0.027), showing that, on similar lines,
patients with an MDD were characterized by the least typical pattern.
Specifically, although the three groups were generally faster in cate-
gorizing basic compared to subtle emotions, the difference in their re-
sponse times following the categorization of basic compared to subtle
emotions was somewhat smaller compared to the other two groups
(contrast Basic versus Subtle Emotion for MDD t(17.077)= 5.211,
p<0.001; schizophrenia t(17.077)= 5.954, p<0.001; healthy con-
trols t(17.077)= 8.257, p<0.001). After additionallycontrolling for
IQ, EQ and TAS, these results remained unchanged (ps≥ 0.171) (also
see Supplement Table 1).
Since the observed interaction between Group and Emotion Type
might be modulated by the specific emotion that was presented, we
investigated this possibility in a model that instead of the factor
Emotion Type (basic or subtle) contained the factor Emotion (sad,
angry, fearful, disgusted, happy, gloomy, relaxed, shy, startled, apa-
thetic). In this model, the interactions between Group * Emotion (F
(17.077)= 2.392, p<0.01) and Group * Experimental Condition (F
(17.077)= 5.286, p=0.005)) remained significant (also see Table 4).
Compared to healthy controls, patients with schizophrenia specifically,
were slower than controls when recognizing anger and sadness (angry: t
(17.007)= 2.242, p=0.025; sad: t(17.007)= 2.048, p=0.041) (also
see Fig. 1a). Their response times did not significantly differ from the
depressed group in any of the conditions (stats p≥ 0.09).
3.2.2. Confirmation rates of emotions
In a generalized mixed model that was similar to the reaction time
model, but included a binomial distribution instead, we analyzed par-
ticipants’ responses to the question of whether a certain emotion label
matched with the expression on the observed face (Noh Mask or
Japanese Female Face). Similar to the reaction times results, an inter-
action between Group * Experimental Condition was observed (F
(17.272)= 4.257, p=0.014) and again the MDD patients were most
deviant (also see Table 5). Specifically, in contrast to healthy controls
and patients with schizophrenia, who tended to report “yes” more often
when the question concerned a real facial expression compared to an
expression from a Noh mask, MDD patients tended to give more “yes”
responses following the Noh mask stimuli (see also Fig. 1b). Please note
that although the interaction was significant, none of the follow-up
simple contrasts were significant (ps≥ 0.056). Again, we verified that
TAS, EQ or IQ were not modulating any of these effects and did not
predict responses in general either (ps≥ 299) (see Supplement
Table 2).
Summarizing the present results, all groups were slower to react on
the Noh mask condition. Patients with schizophrenia were significantly
slower than healthy controls only on the emotions anger and sadness.
Patients with an MDD showed less difference in reaction times between
the Noh mask and the Japanese female face stimuli and also showed
fewer differences in reaction to basic versus subtle emotions. MDD
patients also confirmed emotional expressions more often on the
Japanese female face stimulus. IQ, age and cognitive function did not
have a relevant impact on the results.
4. Discussion
In the current study we used a novel neuropsychological task to
investigate the perception of ambiguous expressions of emotions in
patients with schizophrenia in comparison to patients with an MDD and
healthy controls, evaluating performance and characterizing group
differences. We employed a task with a singular stimulus of East-Asian
origin (Noh mask), which may have specific advantages over standard
Table 1
Social and clinical data (means and standard deviations)* indicates significant results. 1 n=31; Abbreviations: BDI=Beck Depression Inventory; CGI=Clinical
Global Impression; CPZ=chlorpromazine equivalents; GAF=Global Assessment of Functioning; MADRS=Montgomery-Asberg Depression Rating Scale;
EQ=Empathy Quotient (cut-off score≤ 30); MDD=major depressive disorder; MWTB=Multiple Choice Vocabulary Intelligence Test; PANSS=Positive and
Negative Syndrome Scale; TAS=Toronto-Alexithymia-Scale (cut-off score≥ 54); TMT=Trail Making Test, we here present results as transformed IQ scores.
Schizophrenia (n=32) MDD (n=32) Healthy (n=32) Statistics
Age (years) 36.6 (10.6) 31.7 (10.0) 36.5 (8.9) F (2,93)= 2.5; p=0.08
Gender 12 ♀, 20 ♂ 16 ♀, 16 ♂ 12 ♀, 20 ♂ χ2=1.357; p=0.3
Education (years) 11.8 (1.5) 12.2 (1.2) 12.0 (1.4) F (2,93)= 0.8; p=0.4
Duration of illness (years) 9.4 (8.4) 2.8 (4.7) – U=−3.9; p<0.001
Verbal IQ (MWT-B) 106.9 (15.0) 110.7 (14.2) 117.3 (16.0) F (2,93)= 3.9; p=0.02
TMT – A 87.1 (16.7) 109.8 (18.9)1 104.3 (14.8) F (2,92)= 15.7; p<0.001*
TMT – B 88.2 (17.7) 111.9 (14.1)1 109.3 (15.0) F (2,92)= 21.9; p<0.001*
BDI 10.6 (5.4) 22.06 (8.2) 1.3 (2.1) F (2,93)= 103.5; p<0.001*
MADRS 11.9 (6.5)1 25.2 (7.1)1 0.7 (1.6) F (2,90)= 144.5; p<0.001*
EQ 38.4 (11.1) 32.3 (9.5) 42.6 (10.3) F (2,93)= 8.2; p<0.001*
TAS Sum score 47.3 (8.8) 50.5 (8.2) 37.3 (5.3) F (2,93)= 26.6; p<0.001*
TAS subscale 1 16.0 (5.2) 19.0 (5.7) 9.6 (2.2) F (2,93)= 34.6; p<0.001*
TAS subscale 2 15.1 (4.2) 15.7 (3.3) 10.9 (3.3) F (2,93)= 16.3; p<0.001*
TAS subscale 3 16.2 (2.8) 15.8 (3.3) 16.8 (0.6) F (2,93)= 0.9; p=0.4
GAF 56.5 (11.8)1 56.8 (8.5)1 – U=−0.9; p=0.9
CGI 5.4 (0.9)1 5.6 (0.8)1 – U=−0.6; p=0.6
PANSS Sum 59.5 (15.1) – – –
PANSS+ 13.5 (4.6) – – –
PANSS - 15.2 (6.8) – – –
PANSS General 31.6 (7.4) – – –
PANSS anxiety 2.6 (1.3) – – –
CPZ 870.1 – – –
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emotion identification tasks and might serve as a diagnostic tool for
detecting schizophrenia. In addition, we investigated the perception of
emotions from a human face as a control task, adopting a similar
presentation mode. In addition to basic expressions of emotion, more
subtle or complex expressions were investigated.
Our results showed subtle differences between patients with
Table 2
Means and standard deviations for reaction times and percentage of positive confirmation rates over the experimental groups.
Condition Schizophrenia MDD Healthy
Mean reaction times and confirmation rates over all conditions
Reaction times
Noh mask 2,210.99 (1,468.440) 1,962.43 (1,155.601) 2,046.03 (1,113.817)
Japanese female face 2,358.47 (1,423.411) 2,147.80 (1,244.095) 2,115.77 (1,189.297)
Confirmation rates
Noh mask 25.1% 28.9% 28.3%
Japanese female face 28.6% 27.9% 27.9%
Mean reaction times and confirmation rates over basic and subtle emotions
Reaction times
Noh mask
Basic 2,069.99 (1,466.613) 1,979.76 (1,153.356) 1,830.51 (1,112.686)
Subtle 2,287.15 (1,465.155) 2,090.23 (1,084.740) 2,050.63 (1,175.513)
Japanese female face
Basic 2,262.55 (1,425.638) 2,009.90 (1,192.303) 1,981.39 (1,168.377)
Subtle 2,422.28 (1,418.757) 2,186.67 (1,182.330) 2,259.49 (1,280.690)
Confirmation rates
Noh mask
Basic 24.6% 26.6% 27,5%
Subtle 25.5% 29.3% 29.7%
Japanese female face
Basic 20.7% 19.8% 22.0%
Subtle 33.9% 33.3% 39.7%
Mean reaction times and confirmation rates over all emotion items
Reaction times
Noh mask
Sad 2,107.24 (1,469.018) 1,979.53 (1,139.118) 1,685.82 (945.705)
Angry 2,262.13 (1,595.482) 1,913.99 (1,088.795) 1,744.61 (974.818)
Fearful 2,048.95 (1,463.928) 1,907,71 (1,171.615) 1,792.73 (1,138.989)
Happy 2,212.23 (1,547.668) 2,225.71 (1,212.871) 2,072.01 (1,256.627)
Disgusted 2,021.60 (1,383.777) 1,805.49 (1,047.094) 1,771.12 (1,052.924)
Gloomy 2,487.73 (1,482.928) 2,165.16 (1,017.336) 2,072.71 (1,079.655)
Relaxed 2,263.45 (1,399.870) 2,143.41 (1,075.784) 2,284.05 (1,276.744)
Shy 2,297.09 (1,473.785) 2,203.55 (1,124.095) 2,180.37 (1,267.586)
Startled 2,132.09 (1,312.718) 1,892.76 (926.972) 1,842.68 (1,122.316)
Apathetic 2,280.42 (1,501.689) 2,223.86 (1,213.192) 2,183.25 (1,216.840)
Japanese female face
Sad 2,175.96 (1,363.574) 1,982.45 (1,159.721) 1,900.80 (1,030.713)
Angry 2,290.20 (1,413.217) 2,011.96 (1,192.397) 2,052.05 (1,205.105)
Fearful 2,439.54 (1,587.482) 2,075.71 (1,258.549) 2,031.80 (1,273.775)
Happy 2,290.56 (1,400.571) 2,083.06 (1,197.626) 2,086.79 (1,201.915)
Disgusted 2,144.17 (1,326.136) 1,896.99 (1,146.409) 1,905.60 (1,148.743)
Gloomy 2,652.63 (1,456.287) 2,311.66 (1,173.954) 2,409.46 (1,187.231)
Relaxed 2,444.63 (1,485.960) 2,284.01 (1,242.567) 2,338.76 (1,388.959)
Shy 2,367.48 (1,305.356) 2,222.79 (1,216.835) 2,222.12 (1,209.215)
Startled 2,371.00 (1,400.435) 2,145.71 (1,223.081) 2,168.24 (1,287.550)
Apathetic 2,410.42 (1,430.901) 2,144.14 (1,013.278) 2,367.68 (1,367.069)
Confirmation rates
Noh mask
Sad 11.1% 19.8% 13.2%
Angry 5.9% 6.3% 12.8%
Fearful 11.1% 13.9% 16.0%
Happy 67.4% 62.2% 68.8%
Disgusted 8.7% 10.8% 12.2%
Gloomy 18.1% 16.3% 18.8%
Relaxed 65.6% 74.4% 63.9%
Shy 31.6% 36.5% 40.6%
Startled 10.4% 12.5% 12.8%
Apathetic 21.5% 29.9% 29.5%
Japanese female face
Sad 15.6% 17.7% 20.1%
Angry 16.0% 20.1% 21.9%
Fearful 22.2% 28.5% 28.1%
Happy 32.6% 26.7% 30.2%
Disgusted 12.5% 6.3% 9.4%
Gloomy 41.0% 36.8% 37.8%
Relaxed 51.7% 48.3% 57.6%
Shy 33.0% 32.6% 39.9%
Startled 31.3% 31.9% 31.3%
Apathetic 30.6% 30.2% 49.7%
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schizophrenia, MDD and healthy controls over both tasks that became
visible in interaction effects. Specifically, the factor group (the two
patient groups or controls) interacted with emotion type (basic or
subtle) regarding the reaction times. An interaction between group and
experimental condition was observed in the analyses of both reaction
times and the confirmation rates of emotions. In the section below, we
elaborate on these findings.
For the reaction times, the two interactions with group were mainly
driven by patients with an MDD. First, although all groups were slower
following the Noh mask stimuli than real facial expressions, this dif-
ference was much less prominent in the MDD group compared to the
two other groups. Moreover, in comparison to patients with schizo-
phrenia and healthy controls, patients with an MDD showed smaller
differences in reaction times following basic (typically faster, see also
Dai et al., 2015) compared to subtle emotions (typically slower).
When investigating emotion items specifically, patients with schi-
zophrenia were slower than controls to recognize anger and sadness,
while the reaction times were not significantly different from those of
patients with an MDD. None of these results were modulated by cog-
nitive functioning, IQ or age.
Although our hypothesis of a general reaction time slowing in
schizophrenia was not verified, the results show that specific emotion
items pose a larger burden for patients with schizophrenia. In previous
studies patients with schizophrenia were shown to exhibit an emotion
identification bias, with a deficit in detecting negative emotions
(Takahashi et al., 2004). This was also corroborated in a study by
Minoshita and colleagues (2005), in which patients rated the stimulus
more pleasantly than healthy controls. However, the deficits have to be
considered small. Specific reaction time slowing on certain facial ex-
pressions might lead to impairments in the recognition of specific
emotions and might also lead to interruptions in mutual communica-
tion.
Contrary to our prediction and other findings not verifying reaction
time disadvantages in depression as compared to healthy controls
(Sfärlea et al., 2018), we found larger differences for patients with MDD
in reaction time on one of the experimental tasks and also a larger effect
of subtle and basic emotion items in this patient group. Deficits in the
recognition of ambiguous emotions have been shown in relatives of
depressed patients (Dearing and Gotlib, 2009). On a task with simple
and more complex emotions, patients with a depression had more dif-
ficulties to identify complex emotions as compared to healthy controls
(Yoon et al., 2016). Leppänen et al., (2004) found that patients with a
depression were slower to label neutral faces, which was hypothesized
to present an ambiguous stimulus for patients.
For the confirmation rates of emotion items, again, a significant
interaction effect was observed, while no main group effect was pre-
sent. However, this interaction was, again, driven by MDD patients,
whose responses did not differ between the Noh mask and the Japanese
female face. Healthy controls and schizophrenia patients more often
indicated an emotion item positively when the real human face was
presented. However, in patients with an MDD no such difference seems
to be present. In fact, the numbers point to the opposite. Here, our
hypothesis that patients with schizophrenia identify negative items less
frequently was not corroborated. While patients with an MDD have
been shown to display a bias toward negative emotions (Hale, 1998), it
was also not corroborated in our study.
We did not succeed in identifying meaningful group differences with
the task, but we were able to show interaction effects with group. As
hypothesized taking into account our previous work, we think that the
stimuli of Asian origin were probably not suitable for use in a cross-
cultural sample. It may be assumed that both patient groups and
healthy controls might have had difficulties in assessing the stimuli
rather than inducing a stronger effect on patients with schizophrenia, as
previously hypothesized. In a study investigating patients with
Table 3
Fixed and random effects in a generalized linear mixed model of reaction times (Basic vs. Subtle Emotions) (df= degrees of freedom). Significant p-values shown in
bold. Fixed factors included Group (3: Schizophrenia; MDD; Control Group), Emotion Type (2: Basic Emotion; Subtle Emotion) and Experimental Condition (2: Noh
Mask; Japanese Female Face).
Fixed factors Df F value Significance level
Group 2,17.1 1.038 0.354
Emotion type 1,17.1 141.065 < 0.001
Experimental Condition 1,17.1 63.576 < 0.001
Emotion type * Experimental Condition 1,17.1 0.188 0.665
Emotion type * Group 2,17.1 3.610 0.027
Experimental Condition * Group 2,17.1 5.442 0.004
Emotion type * Experimental Condition * Group 2,17.1 1.103 0.332
Random effect Estimate Standard error Z p-value 95% Confidence interval
Lower Upper
Variance 0.265 0.003 92.209 < 0.001 0.260 0.271
Intercept 0.082 0.012 6.695 < 0.001 0.061 0.109
Table 4
Fixed and random effects in a generalized linear mixed model of reaction times (all emotions included) (df= degrees of freedom). Significant p-values shown in bold.
Fixed factors included Group (3: Schizophrenia; MDD; Control Group) and Emotion (10: sad, angry, fearful, disgusted, happy, gloomy, relaxed, shy, startled,
apathetic) and Experimental Condition (2: Noh Mask; Japanese Female Face).
Fixed factors Df F value Significance level
Group 2,17.1 1.007 0.365
Emotion 1,17.1 36.190 < 0.001
Experimental Condition 1,17.1 72.130 < 0.001
Emotion * Experimental Condition 1,17.1 2.372 0.001
Emotion * Group 2,17.1 2.292 0.001
Experimental Condition * Group 2,17.1 5.286 0.005
Emotion * Experimental Condition * Group 2,17.1 0.927 0.545
Random effect Estimate Standard error Z p-value 95% Confidence interval
Lower Upper
Variance 0.082 0.012 6.698 < 0.001 0.061 0.110
Intercept 0.262 0.003 92.152 < 0.001 0.256 0.267
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schizophrenia, researchers found a small effect of culture, with
Caucasian patients recognizing disgust in Caucasian face models better
than in models of Asian origin (Okada et al., 2015).
However, we still think that our task might be of a diagnostic value.
A potential utility of the Noh mask test could lie in a transdiagnostic
capacity, adopting a phenomenological approach. Here, patients with
certain symptom constellations might react more similarly, in-
dependent of the disease category. Assessing patients within the spec-
trum of mental disorders could be a meaningful approach, e.g.,
assessing patients with psychotic mania or psychotic depression. On the
basis of patients’ reaction times and/or emotion confirmation patterns
it might also be possible to predict whether patients are more likely to
fall in the depression or schizophrenia group, or might be more likely to
experience a particular type of psychopathology or a social dis-
advantage (e.g., social isolation). Whether that is the case needs to be
determined in further research, using these measures to predict diag-
nosis/group from the data. Such methods are not only cost-effective,
e.g., compared to genetic investigations, but might also lead to
Fig. 1. (a) Interaction Group * Emotion: Reaction time of three groups over all emotion items. *indicates significant group effects.
(b) Interaction Group * Experimental Condition: Emotion confirmation rates over the three groups over both experimental conditions.
Table 5
Fixed and random effects in a generalized linear mixed model of confirmation rates of emotions (df= degrees of freedom). Significant p-values shown in bold. Fixed
factors included Group (3: Schizophrenia; MDD; Control Group), Emotion Type (2: Basic Emotion; Subtle Emotion) and Experimental Condition (2: Noh Mask;
Japanese Female Face).
Fixed factors Df F value Significance level
Group 2,17.268 0.930 0.394
Emotion type 1,17.268 151.742 <0.001
Experimental Condition 1,17.268 0.523 0.470
Emotion type * Experimental Condition 1,17.268 89.644 <0.001
Emotion type * Group 2,17.268 1.035 0.355
Experimental condition * Group 2,17.268 3.214 0.040
Emotion type * Experimental Condition * group 2,17.268 0.671 0.511
Random effect Estimate Standard error Z p-value 95% Confidence interval
Lower Upper
Variance 1.000 – – – – –
Intercept 0.575 0.094 6.150 < 0.001 0.418 0.791
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transdiagnostic concepts, modeling complex relationships among cate-
gories contributing to the etiology of mental disorders (Miller and
Rockstroh, 2013). The Noh mask test might also be used in larger
packages of cognitive tasks to address a variety of cognitive func-
tioning, as, for instance, in the MATRICS Consensus Cognitive Battery
(Kern et al., 2008; Nuechterlein et al., 2008) which targets multiple
cognitive domains. Future studies could also complement the in-
vestigation of emotion identification strategies using e.g., eye-tracking
or functional imaging methods. Eye-tracking methods, in particular,
provide the opportunity to identify (aberrant) visual exploration paths
in patients with schizophrenia and might thus find abnormal eye
movement when scanning the mask in contrast to healthy controls or
other patient groups (Loughland et al., 2002). Moreover, emotion
identification in morphed faces investigated with functional neuroi-
maging methods suggested that sensitivity of emotion identification
was altered in patients with schizophrenia (Maher et al., 2016).
As a limitation of our study, all patients with schizophrenia received
medication. It must be assumed that cognitive functioning of patients
(with a neuroleptic) impacts the test results in emotion identification.
However, recent studies on the impact of antipsychotic treatment on
cognitive performance support the idea that negative effects on emotion
identification are negligible (Gabay et al., 2015). Moreover, in this task
we used emotion-labeling, which has been shown to be deficient in
patients with affective disorders and schizophrenia (Feinberg et al.,
1986). In a study by Romero-Ferreiro et al., (2015) for example, pa-
tients with schizophrenia who had to assign emotions to facial ex-
pressions less frequently labeled negative emotions correctly. However,
in our task at hand, there were no right or wrong answers, which makes
the process of data analysis more complex. Consequently, the results
need to be interpreted with more caution.
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